Close Menu

NEW YORK – The GenomeWeb Index rose more than 9 percent in May as investors continued to reward companies' efforts to develop new diagnostics for the SARS-CoV-2 virus, as well as positive earnings reports.

The index also outperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which rose 4 percent, 7 percent, and 8 percent, respectively. Individual stock performances in the GenomeWeb Index were largely positive in May, as 24 of the 32 stocks saw gains and just eight saw losses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small study has found that a rapid test for SARS-CoV-2 works about as well as a PCR test, according to the New York Times.

New Scientist reports that a new genetic analysis suggests some saber-toothed cats may have lived in packs and been fast runners.

PLOS is piloting a new model under which research institutions pay a flat fee for its researchers to publish in its journals, Science reports.

In Science this week: honey bees recognize colony mates by their gut microbiomes, and more.